[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 26, 2011

Blood Transfusion and Cardiac Surgery

JAMA. 2011;305(4):357-359. doi:10.1001/jama.2011.14

To the Editor: In their study of transfusion requirements after cardiac surgery, Dr Hajjar and colleagues1 concluded that the use of a restrictive transfusion strategy (a hematocrit level less than 24% for red cell transfusion) was noninferior to a liberal strategy (a hematocrit level less than 30%) in terms of a combined outcome of 30-day all-cause mortality and morbidity among patients undergoing elective cardiac surgery. The authors' conclusion was based and dependent on a sample size estimated on an 8% noninferiority margin, ie, that the outcome of interest does not differ by more 8%.

First Page Preview View Large
First page PDF preview
First page PDF preview